Author:
Goldstein M.,Meller E.,Adler C. H.
Reference19 articles.
1. Adler, C.H., Meller, E. and Goldstein, M. (1985). Recovery of alpha2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Eur. J. Pharmacol. 116, 1178–178.
2. Ariens, E.J., Van Rossum, J.M. and Koopman, P.C. (1960). Receptor reserve and threshold phenomena. Arch. Int. Pharmacodyn Ther. 127, 459–478.
3. Cambridge, D. (1981). UK-14,304, a potent and selective alpha2-agonist for the characterization of alpha-adrenoreceptor subtypes. Eur. J. Pharmacol. 72, 413–415.
4. Carlsson, A. (1983). Dopamine receptor agonists: intrinsic activity vs. state of receptor. J. Neur. Trans. 57, 309–315.
5. Clark, D., Hjorth, S. and Carlsson, A. (1985). Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J. Neur. Trans. 62, 171–207.